Advertisement

Journal of Neural Transmission

, Volume 114, Issue 1, pp 135–147 | Cite as

Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

  • G. Mudo
  • N. Belluardo
  • K. Fuxe
Article

Summary.

In the present work we reviewed recent advances concerning neuroprotective/neurotrophic effects of acute or chronic nicotine exposure, and the signalling pathways mediating these effects, including mechanisms implicated in nicotine addiction and nAChR desensitization. Experimental and clinical data largely indicate long-lasting effects of nicotine and nicotinic agonists that imply a neuroprotective/neurotrophic role of nAChR activation, involving mainly α7 and α4β2 nAChR subtypes, as evidenced using selective nAChR agonists. Compounds interacting with neuronal nAChRs have the potential to be neuroprotective and treatment with nAChR agonists elicits long-lasting neurotrophic effects, e.g. improvement of cognitive performance in a variety of behavioural tests in rats, monkeys and humans. Nicotine addiction, which is mediated by interaction with nACh receptors, is believed to involve the modification of signalling cascades that modulate synaptic plasticity and gene expression. Desensitization, in addition to protecting cells from uncontrolled excitation, is recently considered as a form of signal plasticity. nAChR can generate these longe-lasting effects by elaboration of complex intracellular signals that mediate medium to long-term events crucial for neuronal maintenance, survival and regeneration. Although a comprehensive survey of the gene-based molecular mechanisms that underlie nicotine effects has yet not been performed a growing amount of data is beginning to improve our understanding of signalling mechanisms that lead to neurotrophic/neuroprotective responses. Evidence for an involvement of the fibroblast growth factor-2 gene in nAChR mechanisms mediating neuronal survival, trophism and plasticity has been obtained. However, more work is needed to establish the mechanisms involved in the effects of nicotinic receptor subtype activation from cognition-enhancing and neurotrophic effects to smoking behaviour and to determine more precisely the therapeutic objectives in potential nicotinic drug treatments of neurodegenerative diseases.

Keywords: nAChR, nicotinic agonists, neurotrophic factors, FGF-2, neuroprotection, neurotrophism, addiction, desensitization, neuroplasticity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrous, DN, Adriani, W, Montaron, MF, Aurousseau, C, Rougon, G, Le, MM, Piazza, PV 2002Nicotine self-administration impairs hippocampal plasticityJ Neurosci2236563662PubMedGoogle Scholar
  2. Allen, TB, McEvoy, JP 2002Galantamine for treatment-resistant schizophreniaAm J Psychiatry15912441245PubMedGoogle Scholar
  3. Anderson, KJ, Dam, D, Lee, S, Cotman, CW 1988Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivoNature332360361PubMedGoogle Scholar
  4. Andersson, K, Fuxe, K, Agnati, LF 1981Effects of single injections of nicotine on the ascending dopamine pathways in the rat. Evidence for increases of dopamine turnover in the mesostriatal and mesolimbic dopamine neuronsActa Physiol Scand112345347PubMedGoogle Scholar
  5. Arendash, GW, Sengstock, GJ, Sanberg, PR, Kem, WR 1995Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21Brain Res674252259PubMedGoogle Scholar
  6. Banerjee, C, Nyengaard, JR, Wevers, A, de Vos, RA, Jansen Steur, EN, Lindstrom, J, Pilz, K, Nowacki, S, Bloch, W, Schroder, H 2000Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer’s and Parkinson’s disease – a stereological approachNeurobiol Dis7666672PubMedGoogle Scholar
  7. Bannon, AW, Decker, MW, Holladay, MW, Curzon, P, Donnelly-Roberts, D, Puttfarcken, PS, Bitner, RS, Diaz, A, Dickenson, AH, Porsolt, RD, Williams, M, Arneric, SP 1998Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptorsScience2797781PubMedGoogle Scholar
  8. Barde, YA 1989Trophic factors and neuronal survivalNeuron215251534PubMedGoogle Scholar
  9. Barnes, CA, Meltzer, J, Houston, F, Orr, G, McGann, K, Wenk, GL 2000Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptorsNeuroscience991723PubMedGoogle Scholar
  10. Baron, JA 1986Cigarette smoking and Parkinson’s diseaseNeurology3614901496PubMedGoogle Scholar
  11. Baron, JA 1996Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spuriousBr Med Bull525873PubMedGoogle Scholar
  12. Belluardo, N, Blum, M, Mudo, G, Andbjer, B, Fuxe, K 1998Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the ratNeuroscience83723740PubMedGoogle Scholar
  13. Belluardo, N, Mudo, G, Blum, M, Cheng, Q, Caniglia, G, Dell’Albani, P, Fuxe, K 1999aThe nicotinic acetylcholine receptor agonist (+/−)-epibatidine increases FGF-2 mRNA and protein levels in the rat brainBrain Res Mol Brain Res7498110Google Scholar
  14. Belluardo, N, Mudo, G, Blum, M, Fuxe, K 2000Central nicotinic receptors, neurotrophic factors and neuroprotectionBehav Brain Res1132134PubMedGoogle Scholar
  15. Belluardo, N, Mudo, G, Caniglia, G, Cheng, Q, Blum, M, Fuxe, K 1999bThe nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regionsNeuroreport1039093913Google Scholar
  16. Belluardo, N, Olsson, PA, Mudo’, G, Sommer, WH, Amato, G, Fuxe, K 2005Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortexNeuroscience133787796PubMedGoogle Scholar
  17. Belluardo, N, Wu, G, Mudo, G, Hansson, AC, Pettersson, R, Fuxe, K 1997Comparative localization of fibroblast growth factor receptor-1, -2, and -3 mRNAs in the rat brain: in situ hybridization analysisJ Comp Neurol379226246PubMedGoogle Scholar
  18. Bencherif, M, Fowler, K, Lukas, RJ, Lippiello, PM 1995Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brainJ Pharmacol Exp Ther275987994PubMedGoogle Scholar
  19. Benwell, ME, Balfour, DJ, Anderson, JM 1988Evidence that tobacco smoking increases the density of (–)-[3H]nicotine binding sites in human brainJ eurochem5012431247Google Scholar
  20. Bliss, TV, Lomo, T 1973Long-lasting potentiation of synaptic transmissionin the dentate area of the anaesthetized rabbit following stimulation of the perforant pathJ Physiol232331356PubMedGoogle Scholar
  21. Blum, M, Wu, G, Mudo, G, Belluardo, N, Andersson, K, Agnati, LF, Fuxe, K 1996Chronic continuous infusion of (–)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned ratNeuroscience70169177PubMedGoogle Scholar
  22. Bonci, A, Malenka, RC 1999Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental areaJ Neurosci1937233730PubMedGoogle Scholar
  23. Broide, RS, Leslie, FM 1999The alpha7 nicotinic acetylcholine receptor in neuronal plasticityMol Neurobiol20116PubMedGoogle Scholar
  24. Brunzell, DH, Russell, DS, Picciotto, MR 2003In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J miceJ Neurochem8414311441PubMedGoogle Scholar
  25. Buccafusco, JJ, Letchworth, SR, Bencherif, M, Lippiello, PM 2005Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordanceTrends Pharmacol Sci26352360PubMedGoogle Scholar
  26. Burghaus, L, Schutz, U, Krempel, U, Lindstrom, J, Schroder, H 2003Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patientsParkinsonism Relat Disord9243246PubMedGoogle Scholar
  27. Chadi, G, Moller, A, Rosen, L, Janson, AM, Agnati, LA, Goldstein, M, Ogren, SO, Pettersson, RF, Fuxe, K 1993Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusionExp Brain Res97145158PubMedGoogle Scholar
  28. Chang, KT, Berg, DK 2001Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neuronsNeuron32855865PubMedGoogle Scholar
  29. Changeux, JP, Bertrand, D, Corringer, PJ, Dehaene, S, Edelstein, S, Lena, C, Le, NN, Marubio, L, Picciotto, M, Zoli, M 1998Brain nicotinic receptors: structure and regulation, role in learning and reinforcementBrain Res Rev26198216PubMedGoogle Scholar
  30. Cheng, B, Mattson, MP 1991NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasisNeuron710311041PubMedGoogle Scholar
  31. Connor, B, Dragunow, M 1998The role of neuronal growth factors in neurodegenerative disorders of the human brainBrain Res Rev27139PubMedGoogle Scholar
  32. Court, J, Martin-Ruiz, C, Piggott, M, Spurden, D, Griffiths, M, Perry, E 2001Nicotinic receptor abnormalities in Alzheimer’s diseaseBiol Psychiatry49175184PubMedGoogle Scholar
  33. Couturier, S, Bertrand, D, Matter, JM, Hernandez, MC, Bertrand, S, Millar, N, Valera, S, Barkas, T, Ballivet, M 1990A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTXNeuron5847856PubMedGoogle Scholar
  34. Cox, ME, Ely, CM, Catling, AD, Weber, MJ, Parsons, SJ 1996Tyrosine kinases are required for catecholamine secretion and mitogen-activated protein kinase activation in bovine adrenal chromaffin cellsJ Neurochem6611031112PubMedCrossRefGoogle Scholar
  35. Dajas-Bailador, FA, Lima, PA, Wonnacott, S 2000The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanismNeuropharmacology3927992807PubMedGoogle Scholar
  36. Damaj, MI 2000The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in miceEur J Pharmacol404103110PubMedGoogle Scholar
  37. Dani, JA 2001Overview of nicotinic receptors and their roles in the central nervous systemBiol Psychiatry49166174PubMedGoogle Scholar
  38. Dani, JA, Ji, D, Zhou, FM 2001Synaptic plasticity and nicotine addictionNeuron31349352PubMedGoogle Scholar
  39. De La Garza, VW 2003Pharmacologic treatment of Alzheimer’s disease: an updateAm Fam Physician6813651372Google Scholar
  40. Decker, MW, Brioni, JD, Bannon, AW, Arneric, SP 1995Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeuticsLife Sci56545570PubMedGoogle Scholar
  41. Decker, MW, Brioni, JD, Sullivan, JP, Buckley, MJ, Radek, RJ, Raszkiewicz, JL, Kang, CH, Kim, DJ, Giardina, WJ, Wasicak, JT 1994a(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterizationJ Pharmacol Exp Ther270319328Google Scholar
  42. Decker, MW, Curzon, P, Brioni, JD, Arneric, SP 1994bEffects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned ratsEur J Pharmacol261217222Google Scholar
  43. Deutsch, SI, Rosse, RB, Schwartz, BL, Weizman, A, Chilton, M, Arnold, DS, Mastropaolo, J 2005Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophrenia. IsrJ Psychiatry Relat Sci423344Google Scholar
  44. DiFranza, JR, Wellman, RJ 2003Preventing cancer by controlling youth tobacco useSemin Oncol Nurs19261267PubMedGoogle Scholar
  45. Dono, R, Texido, G, Dussel, R, Ehmke, H, Zeller, R 1998Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient miceEMBO J1742134225PubMedGoogle Scholar
  46. Dunckley, T, Lukas, RJ 2003Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell lineJ Biol Chem2781563315640PubMedGoogle Scholar
  47. Fenster, CP, Beckman, ML, Parker, JC, Sheffield, EB, Whitworth, TL, Quick, MW, Lester, RA 1999Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase CMol Pharmacol55432443PubMedGoogle Scholar
  48. Ferchmin, PA, Perez, D, Eterovic, VA, de, VJ 2003Nicotinic receptors differentially regulate N-methyl-D-aspartate damage in acute hippocampal slicesJ Pharmacol Exp Ther30510711078PubMedGoogle Scholar
  49. Ferrari, G, Minozzi, MC, Toffano, G, Leon, A, Skaper, SD 1989Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in cultureDev Biol133140147PubMedGoogle Scholar
  50. Forgacs, PB, Bodis-Wollner, I 2004Nicotinic receptors and cognition in Parkinson’s Disease: the importance of neuronal synchronyJ Neural Transm11113171331PubMedGoogle Scholar
  51. Fratiglioni, L, Wang, HX 2000Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studiesBehav Brain Res113117120PubMedGoogle Scholar
  52. Freedman, R 2005The choice of antipsychotic drugs for schizophreniaN Engl J Med35312861288PubMedGoogle Scholar
  53. Fujii, S, Sumikawa, K 2001Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampusBrain Res894347353PubMedGoogle Scholar
  54. Fuxe, K, Andersson, K, Eneroth, P, Harfstrand, A, Agnati, LF 1989Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implicationsPsychoneuroendocrinology141941PubMedGoogle Scholar
  55. Fuxe, K, Andersson, K, Harfstrand, A, Agnati, LF 1986Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smokeJ Neural Transm671529PubMedGoogle Scholar
  56. Fuxe, K, Janson, AM, Jansson, A, Andersson, K, Eneroth, P, Agnati, LF 1990Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransectionNaunyn Schmiedebergs Arch Pharmacol341171181PubMedGoogle Scholar
  57. Fuxe, K, Tinner, B, Zoli, M, Pettersson, RF, Baird, A, Biagini, G, Chadi, G, Agnati, LF 1996Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brainJ Chem Neuroanat111335PubMedGoogle Scholar
  58. Geerts, H 2005Indicators of neuroprotection with galantamineBrain Res Bull64519524PubMedGoogle Scholar
  59. Giniatullin, R, Nistri, A, Yakel, JL 2005Desensitization of nicotinic Ach receptors: shaping cholinergic signalingTrends Neurosci28371378PubMedGoogle Scholar
  60. Gioanni, Y, Rougeot, C, Clarke, PB, Lepouse, C, Thierry, AM, Vidal, C 1999Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmissionEur J Neurosci111830PubMedGoogle Scholar
  61. Gotti, C, Clementi, F 2004Neuronal nicotinic receptors: from structure to pathologyProg Neurobiol74363396PubMedGoogle Scholar
  62. Gould, TJ, Stephen, HJ 2003Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-trainingNeurobiol Learn Mem80147157PubMedGoogle Scholar
  63. Gray, R, Rajan, AS, Radcliffe, KA, Yakehiro, M, Dani, JA 1996Hippocampal synaptic transmission enhanced by low concentrations of nicotineNature383713716PubMedGoogle Scholar
  64. Groenewegen, HJ, Uylings, HB 2000The prefrontal cortex and the integration of sensory, limbic and autonomic informationProg Brain Res126328PubMedGoogle Scholar
  65. Gueorguiev, VD, Frenz, CM, Ronald, KM, Sabban, EL 2004Nicotine and epibatidine triggered prolonged rise in calcium and TH gene transcription in PC12 cellsEur J Pharmacol5063746PubMedGoogle Scholar
  66. Gueorguiev, VD, Zeman, RJ, Meyer, EM, Sabban, EL 2000Involvement of alpha7 nicotinic acetylcholine receptors in activation of tyrosine hydroxylase and dopamine beta-hydroxylase gene expression in PC12 cellsJ Neurochem7519972005PubMedGoogle Scholar
  67. Hardingham, GE, Arnold, FJ, Bading, H 2001Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activityNat Neurosci4261267PubMedGoogle Scholar
  68. Harlan, RE, Garcia, MM 1998Drugs of abuse and immediate-early genes in the forebrainMol Neurobiol16221267PubMedGoogle Scholar
  69. Harrist, A, Beech, RD, King, SL, Zanardi, A, Cleary, MA, Caldarone, BJ, Eisch, A, Zoli, M, Picciotto, MR 2004Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptorSynapse54200206PubMedGoogle Scholar
  70. Heisenberg, CP, Cooper, JD, Berke, J, Sofroniew, MV 1994NMDA potentiates NGF-induced sprouting of septal cholinergic fibresNeuroreport5413416PubMedCrossRefGoogle Scholar
  71. Henderson, LP, Gdovin, MJ, Liu, C, Gardner, PD, Maue, RA 1994Nerve growth factor increases nicotinic ACh receptor gene expression and current density in wild-type and protein kinase A-deficient PC12 cellsJ Neurosci1411531163PubMedGoogle Scholar
  72. Hu, M, Liu, QS, Chang, KT, Berg, DK 2002Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathwaysMol Cell Neurosci21616625PubMedGoogle Scholar
  73. Huerta, PT, Lisman, JE 1993Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic stateNature364723725PubMedGoogle Scholar
  74. Impey, S, Obrietan, K, Storm, DR 1999Making new connections: role of ERK/MAP kinase signaling in neuronal plasticityNeuron231114PubMedGoogle Scholar
  75. Janson, AM, Fuxe, K, Agnati, LF, Jansson, A, Bjelke, B, Sundstrom, E, Andersson, K, Harfstrand, A, Goldstein, M, Owman, C 1989Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male ratProg Brain Res79257265PubMedGoogle Scholar
  76. Janson, AM, Fuxe, K, Agnati, LF, Kitayama, I, Harfstrand, A, Andersson, K, Goldstein, M 1988aChronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransectionBrain Res455332345Google Scholar
  77. Janson, AM, Fuxe, K, Sundstrom, E, Agnati, LF, Goldstein, M 1988bChronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouseActa Physiol Scand132589591CrossRefGoogle Scholar
  78. Janson, AM, Moller, A 1993Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male ratNeuroscience57931941PubMedGoogle Scholar
  79. Jeyarasasingam, G, Tompkins, L, Quik, M 2002Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in cultureNeuroscience109275285PubMedGoogle Scholar
  80. Ji, D, Dani, JA 2000Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneuronsJ Neurophysiol8326822690PubMedGoogle Scholar
  81. Ji, D, Lape, R, Dani, JA 2001Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticityNeuron31131141PubMedGoogle Scholar
  82. Jonnala, RR, Buccafusco, JJ 2001Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonistsJ Neurosci Res66565572PubMedGoogle Scholar
  83. Jonnala, RR, Terry, AV,Jr, Buccafusco, JJ 2002Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivoLife Sci7015431554PubMedGoogle Scholar
  84. Kandel, ER 2001The molecular biology of memory storage: a dialogue between genes and synapsesScience29410301038PubMedGoogle Scholar
  85. Kaneko, S, Maeda, T, Kume, T, Kochiyama, H, Akaike, A, Shimohama, S, Kimura, J 1997Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptorsBrain Res765135140PubMedGoogle Scholar
  86. Kelton, MC, Kahn, HJ, Conrath, CL, Newhouse, PA 2000The effects of nicotine on Parkinson’s diseaseBrain Cogn43274282PubMedGoogle Scholar
  87. Kem, WR 2000The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer’s disease: studies with DMXBA (GTS-21)Behav Brain Res113169181PubMedGoogle Scholar
  88. Kihara, T, Shimohama, S, Sawada, H, Honda, K, Nakamizo, T, Shibasaki, H, Kume, T, Akaike, A 2001alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicityJ Biol Chem2761354113546PubMedGoogle Scholar
  89. Kita, T, Okamoto, M, Nakashima, T 1992Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in ratsLife Sci50583590PubMedGoogle Scholar
  90. Koike, K, Hashimoto, K, Takai, N, Shimizu, E, Komatsu, N, Watanabe, H, Nakazato, M, Okamura, N, Stevens, KE, Freedman, R, Iyo, M 2005Tropisetron improves deficits in auditory P50 suppression in schizophreniaSchizophr Res766772PubMedGoogle Scholar
  91. Kuhn, HG, Winkler, J, Kempermann, G, Thal, LJ, Gage, FH 1997Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brainJ Neurosci1758205829PubMedGoogle Scholar
  92. Lapchak, PA, Araujo, DM, Hefti, F 1994Effects of chronic nerve growth factor treatment on hippocampal [3H]cytisine/nicotinic binding sites and presynaptic nicotinic receptor function following fimbrial transectionsNeuroscience60293298PubMedGoogle Scholar
  93. Lawrence, NS, Ross, TJ, Stein, EA 2002Cognitive mechanisms of nicotine on visual attentionNeuron36539548PubMedGoogle Scholar
  94. Le Novere, N, Changeux, JP 1995Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cellsJ Mol Evol40155172PubMedGoogle Scholar
  95. Le Novere, N, Corringer, PJ, Changeux, JP 2002The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequencesJ Neurobiol53447456PubMedGoogle Scholar
  96. Lena, C, Changeux, JP 1998Allosteric nicotinic receptors, human pathologiesJ Physiol Paris926374PubMedGoogle Scholar
  97. Levin, ED, Bettegowda, C, Blosser, J, Gordon, J 1999AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in ratsBehav Pharmacol10675680PubMedGoogle Scholar
  98. Levin, ED, Bradley, A, Addy, N, Sigurani, N 2002Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memoryNeuroscience109757765PubMedGoogle Scholar
  99. Levin, ED, Christopher, NC, Briggs, SJ, Rose, JE 1993Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projectionBrain Res Cogn Brain Res1137143PubMedGoogle Scholar
  100. Levin, ED, Rezvani, AH 2000Development of nicotinic drug therapy for cognitive disordersEur J Pharmacol393141146PubMedGoogle Scholar
  101. Levin, ED, Simon, BB 1998Nicotinic acetylcholine involvement in cognitive function in animalsPsychopharmacology (Berl)138217230Google Scholar
  102. Li, Y, Papke, RL, He, YJ, Millard, WJ, Meyer, EM 1999Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cellsBrain Res830218225PubMedGoogle Scholar
  103. Lichtensteiger, W, Hefti, F, Felix, D, Huwyler, T, Melamed, E, Schlumpf, M 1982Stimulation of nigrostriatal dopamine neurones by nicotineNeuropharmacology21963968PubMedGoogle Scholar
  104. Lindstrom, J, Schoepfer, R, Whiting, P 1987Molecular studies of the neuronal nicotinic acetylcholine receptor familyMol Neurobiol1281337PubMedCrossRefGoogle Scholar
  105. Lipska, BK 2004Using animal models to test a neurodevelopmental hypothesis of schizophreniaJ Psychiatry Neurosci29282286PubMedGoogle Scholar
  106. Maelicke, A, Samochocki, M, Jostock, R, Fehrenbacher, A, Ludwig, J, Albuquerque, EX, Zerlin, M 2001Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s diseaseBiol Psychiatry49279288PubMedGoogle Scholar
  107. Maelicke, A, Schrattenholz, A, Samochocki, M, Radina, M, Albuquerque, EX 2000Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s diseaseBehav Brain Res113199206PubMedGoogle Scholar
  108. Maggio, R, Riva, M, Vaglini, F, Fornai, F, Molteni, R, Armogida, M, Racagni, G, Corsini, GU 1998Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factorsJ Neurochem7124392446PubMedCrossRefGoogle Scholar
  109. Mai, H, May, WS, Gao, F, Jin, Z, Deng, X 2003A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosisJ Biol Chem27818861891PubMedGoogle Scholar
  110. Mansvelder, HD, McGehee, DS 2000Long-term potentiation of excitatory inputs to brain reward areas by nicotineNeuron27349357PubMedGoogle Scholar
  111. Mansvelder, HD, McGehee, DS 2002Cellular and synaptic mechanisms of nicotine addictionJ Neurobiol53606617PubMedGoogle Scholar
  112. Martin, LF, Kem, WR, Freedman, R 2004Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophreniaPsychopharmacology (Berl)1745464Google Scholar
  113. Martin-Ruiz, CM, Court, JA, Molnar, E, Lee, M, Gotti, C, Mamalaki, A, Tsouloufis, T, Tzartos, S, Ballard, C, Perry, RH, Perry, EK 1999Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer’s diseaseJ Neurochem7316351640PubMedGoogle Scholar
  114. Mattson, MP, Murrain, M, Guthrie, PB, Kater, SB 1989Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitectureJ Neurosci937283740PubMedGoogle Scholar
  115. Mayer, E, Dunnett, SB, Fawcett, JW 1993Mitogenic effect of basic fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursorsBrain Res Dev Brain Res72253258PubMedGoogle Scholar
  116. Messi, ML, Renganathan, M, Grigorenko, E, Delbono, O 1997Activation of alpha7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneuronsFEBS Lett4113238PubMedGoogle Scholar
  117. Mexal, S, Frank, M, Berger, R, Adams, CE, Ross, RG, Freedman, R, Leonard, S 2005Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokersBrain Res Mol Brain Res139317332PubMedGoogle Scholar
  118. Moffett, J, Kratz, E, Stachowiak, MK 1998Increased tyrosine phosphorylation and novel cis-acting element mediate activation of the fibroblast growth factor-2 (FGF-2) gene by nicotinic acetylcholine receptor. New mechanism for trans-synaptic regulation of cellular development and plasticityBrain Res Mol Brain Res55293305PubMedGoogle Scholar
  119. Mudo G, Mauro A, Trentuno D, Curcio E, Belluardo N, Fuxe K (2005) Acute intermittent nicotine treatment enhances proliferation of neuronal precursor cells in the subventricular zone (svz) of adult rat brain. National Congress of the Italian Society for Neuroscience and Joint Italian-Swedish Neuroscience Meeting, 1–4 Ottobre, Lacco Ameno, Ischia (Naples): P 19_02Google Scholar
  120. Nakata, N, Kato, H, Kogure, K 1993Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbilBrain Res605354356PubMedGoogle Scholar
  121. Nanri, M, Yamamoto, J, Miyake, H, Watanabe, H 1998Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbilsJpn J Pharmacol762329PubMedGoogle Scholar
  122. Navarro, HA, Seidler, FJ, Eylers, JP, Baker, FE, Dobbins, SS, Lappi, SE, Slotkin, TA 1989Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brainJ Pharmacol Exp Ther251894900PubMedGoogle Scholar
  123. Nestler, EJ 2001Molecular basis of long-term plasticity underlying addictionNat Rev Neurosci2119128PubMedGoogle Scholar
  124. Nestler, EJ 2002Common molecular and cellular substrates of addiction and memoryNeurobiol Learn Mem78637647PubMedGoogle Scholar
  125. Newhouse, PA, Potter, A, Kelton, M, Corwin, J 2001Nicotinic treatment of Alzheimer’s diseaseBiol Psychiatry49268278PubMedGoogle Scholar
  126. Newhouse, PA, Potter, A, Singh, A 2004Effects of nicotinic stimulation on cognitive performanceCurr Opin Pharmacol43646PubMedGoogle Scholar
  127. Nomikos, GG, Schilstrom, B, Hildebrand, BE, Panagis, G, Grenhoff, J, Svensson, TH 2000Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illnessBehav Brain Res11397103PubMedGoogle Scholar
  128. O’Neill, MJ, Murray, TK, Lakics, V, Visanji, NP, Duty, S 2002The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegenerationCurr Drug Targets CNS Neurol Disord1399411PubMedGoogle Scholar
  129. Ortega, S, Ittmann, M, Tsang, SH, Ehrlich, M, Basilico, C 1998Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2Proc Natl Acad Sci USA9556725677PubMedGoogle Scholar
  130. Pandey, SC 1996Effects of chronic nicotine treatment on the expression of phospholipase C isozymes and the alpha subunit of Gq/11 protein in the rat brainNeurosci Lett212127130PubMedGoogle Scholar
  131. Pandey, SC, Roy, A, Xu, T, Mittal, N 2001Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brainJ Neurochem77943952PubMedGoogle Scholar
  132. Pang, PT, Teng, HK, Zaitsev, E, Woo, NT, Sakata, K, Zhen, S, Teng, KK, Yung, WH, Hempstead, BL, Lu, B 2004Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticityScience306487491PubMedGoogle Scholar
  133. Perry, DC, vila-Garcia, MI, Stockmeier, CA, Kellar, KJ 1999Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studiesJ Pharmacol Exp Ther28915451552PubMedGoogle Scholar
  134. Picciotto, MR, Caldarone, BJ, Brunzell, DH, Zachariou, V, Stevens, TR, King, SL 2001Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implicationsPharmacol Ther9289108PubMedGoogle Scholar
  135. Pugh, PC, Berg, DK 1994Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent mannerJ Neurosci14889896PubMedGoogle Scholar
  136. Pulvirenti, L, Diana, M 2001Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamateRev Neurosci12141158PubMedGoogle Scholar
  137. Quik, M 2004Smoking, nicotine and Parkinson’s diseaseTrends Neurosci27561568PubMedGoogle Scholar
  138. Ripoll, N, Bronnec, M, Bourin, M 2004Nicotinic receptors and schizophreniaCurr Med Res Opin2010571074PubMedGoogle Scholar
  139. Roceri, M, Molteni, R, Fumagalli, F, Racagni, G, Gennarelli, M, Corsini, G, Maggio, R, Riva, M 2001Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatumJ Neurochem76990997PubMedGoogle Scholar
  140. Role, LW, Berg, DK 1996Nicotinic receptors in the development and modulation of CNS synapsesNeuron1610771085PubMedGoogle Scholar
  141. Rowntree, S, Kolb, B 1997Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in ratsEur J Neurosci924322441PubMedGoogle Scholar
  142. Ryan, RE, Ross, SA, Drago, J, Loiacono, RE 2001Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout miceBr J Pharmacol13216501656PubMedGoogle Scholar
  143. Sacco, KA, Bannon, KL, George, TP 2004Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disordersJ Psychopharmacol18457474PubMedGoogle Scholar
  144. Sallette, J, Pons, S, villers-Thiery, A, Soudant, M, Prado de, CL, Changeux, JP, Corringer, PJ 2005Nicotine upregulates its own receptors through enhanced intracellular maturationNeuron46595607PubMedGoogle Scholar
  145. Salomon, AR, Marcinowski, KJ, Friedland, RP, Zagorski, MG 1996Nicotine inhibits amyloid formation by the beta-peptideBiochemistry351356813578PubMedGoogle Scholar
  146. Samaha, AN, Robinson, TE 2005Why does the rapid delivery of drugs to the brain promote addiction?Trends Pharmacol Sci268287PubMedGoogle Scholar
  147. Schneider, JS, Tinker, JP, Menzaghi, F, Lloyd, GK 2003The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeysJ Pharmacol Exp Ther306401406PubMedGoogle Scholar
  148. Seguela, P, Wadiche, J, neley-Miller, K, Dani, JA, Patrick, JW 1993Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calciumJ Neurosci13596604PubMedGoogle Scholar
  149. Semba, J, Miyoshi, R, Kito, S 1996Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neuronsBrain Res735335338PubMedGoogle Scholar
  150. Shim, IS, Won, JS, Lee, JK, Song, DK, Kim, SE, Huh, SO, Kim, YH, Suh, HW 2000Modulatory effect of ginseng total saponin on dopamine release and tyrosine hydroxylase gene expression induced by nicotine in the ratJ Ethnopharmacol70161169PubMedGoogle Scholar
  151. Shimohama, S, Akaike, A, Kimura, J 1996Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formationAnn NY Acad Sci777356361PubMedGoogle Scholar
  152. Shimohama, S, Kihara, T 2001Nicotinic receptor-mediated protection against beta-amyloid neurotoxicityBiol Psychiatry49233239PubMedGoogle Scholar
  153. Singh, IN, Sorrentino, G, Sitar, DS, Kanfer, JN 1998(–)Nicotine inhibits the activations of phospholipases A2 and D by amyloid beta peptideBrain Res800275281PubMedGoogle Scholar
  154. Small, DH, Mok, SS, Bornstein, JC 2001Alzheimer’s disease and Abeta toxicity: from top to bottomNat Rev Neurosci2595598PubMedGoogle Scholar
  155. Sofroniew, MV, Galletly, NP, Isacson, O, Svendsen, CN 1990Survival of adult basal forebrain cholinergic neurons after loss of target neuronsScience247338342PubMedGoogle Scholar
  156. Stachowiak, MK, Moffett, J, Joy, A, Puchacz, E, Florkiewicz, R, Stachowiak, EK 1994Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cellsJ Cell Biol127203223PubMedGoogle Scholar
  157. Summers, KL, Giacobini, E 1995Effects of local and repeated systemic administration of (–)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortexNeurochem Res20753759PubMedGoogle Scholar
  158. Summers, KL, Kem, WR, Giacobini, E 1997Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortexJpn J Pharmacol74139146PubMedGoogle Scholar
  159. Sun, X, Liu, Y, Hu, G, Wang, H 2004Protective effects of nicotine against glutamate-induced neurotoxicity in PC12 cellsCell Mol Biol Lett9409422PubMedGoogle Scholar
  160. Sweatt, JD 2001The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memoryJ Neurochem76110PubMedGoogle Scholar
  161. Tanabe J, Tregellas JR, Martin LF, Freedman R (2005) Effects of Nicotine on Hippocampal and Cingulate Activity During Smooth Pursuit Eye Movement in Schizophrenia. Biol. Psychiatry: PM: 16259965Google Scholar
  162. Tani, Y, Saito, K, Imoto, M, Ohno, T 1998Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain-an in vivo microdialysis studyEur J Pharmacol351181188PubMedGoogle Scholar
  163. Toborek, M, Garrido, R, Malecki, A, Kaiser, S, Mattson, MP, Hennig, B, Young, B 2000Nicotine attenuates arachidonic acid-induced overexpression of nitric oxide synthase in cultured spinal cord neuronsExp Neurol161609620PubMedGoogle Scholar
  164. Tooyama, I, Kawamata, T, Walker, D, Yamada, T, Hanai, K, Kimura, H, Iwane, M, Igarashi, K, McGeer, EG, McGeer, PL 1993Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson’s diseaseNeurology43372376PubMedGoogle Scholar
  165. Vallejo, YF, Buisson, B, Bertrand, D, Green, WN 2005Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanismJ Neurosci2555635572PubMedGoogle Scholar
  166. Vernier, JM, El-Abdellaoui, H, Holsenback, H, Cosford, ND, Bleicher, L, Barker, G, Bontempi, B, Chavez-Noriega, L, Menzaghi, F, Rao, TS, Reid, R, Sacaan, AI, Suto, C, Washburn, M, Lloyd, GK, McDonald, IA 19994-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptorsJ Med Chem4216841686PubMedGoogle Scholar
  167. Wada, E, McKinnon, D, Heinemann, S, Patrick, J, Swanson, LW 1990The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous systemBrain Res5264553PubMedGoogle Scholar
  168. Wada, E, Wada, K, Boulter, J, Deneris, E, Heinemann, S, Patrick, J, Swanson, LW 1989Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the ratJ Comp Neurol284314335PubMedGoogle Scholar
  169. Walters, CL, Cleck, JN, Kuo, YC, Blendy, JA 2005Mu-opioid receptor and CREB activation are required for nicotine rewardNeuron46933943PubMedGoogle Scholar
  170. Wang, H, Sun, X 2005Desensitized nicotinic receptors in brainBrain Res Rev48420437PubMedGoogle Scholar
  171. Warburton, DM, Wesnes, K, Shergold, K, James, M 1986Facilitation of learning and state dependency with nicotinePsychopharmacology (Berl)895559Google Scholar
  172. Wonnacott, S 1990The paradox of nicotinic acetylcholine receptor upregulation by nicotineTrends Pharmacol Sci11216219PubMedGoogle Scholar
  173. Zamani, MR, Allen, YS 2001Nicotine and its interaction with beta-amyloid protein: a short reviewBiol Psychiatry49221232PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • G. Mudo
    • 1
  • N. Belluardo
    • 1
  • K. Fuxe
    • 2
  1. 1.Department of Experimental Medicine, Section of Human PhysiologyUniversity of PalermoPalermoItaly
  2. 2.Department of NeuroscienceKarolinska InstitutetStockholmSweden

Personalised recommendations